Inventor
LAQUERRE SYLVIE
US23 patents
⚠️ This page may combine multiple inventors who share the name “LAQUERRE SYLVIE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ONYX PHARMA INC
7 patentsUS6723316B2Apr 20, 2004
Herpes simplex virus-1 Glycoprotein C mutants for treating unwanted hyperproliferative cell growth
ONYX PHARMA INC71 citations97
US7078030B2Jul 18, 2006
Oncolytic adenovirus
ONYX PHARMA INC21 citations89
US7396679B2Jul 8, 2008
Oncolytic adenovirus
ONYX PHARMA INC9 citations82
US6660259B2Dec 9, 2003
Herpes simplex virus for treating unwanted hyperproliferative cell growth
ONYX PHARMA INC1 citations52
US7556955B2Jul 7, 2009
Nucleic acids encoding Candida kefyr cytosine deaminase
ONYX PHARMA INC0 citations48
US7414113B2Aug 19, 2008
Antibody that specifically binds to Candida kefyr Cytosine deaminase
ONYX PHARMA INC0 citations48
US7141404B2Nov 28, 2006
Candida kefyr cytosine deaminase
ONYX PHARMA INC0 citations48
JANSSEN BIOTECH INC
5 patentsUS11472830B2Oct 18, 2022
Cyclic dinucleotides as sting agonists
JANSSEN BIOTECH INC0 citations61
US12448455B2Oct 21, 2025
Combination therapies with bispecific anti-EGFR/c-met antibodies and third generation EGFR tyrosine kinase inhibitors
JANSSEN BIOTECH INC0 citations58
US11879013B2Jan 23, 2024
Combination therapies with bispecific anti-EGFR/c-Met antibodies and third generation EGFR tyrosine kinase inhibitors
JANSSEN BIOTECH INC0 citations58
US12215160B2Feb 4, 2025
Treatment of patients having c-met exon 14 skipping mutations
JANSSEN BIOTECH INC0 citations47
US11827708B2Nov 28, 2023
Proteins comprising HLA-G antigen binding domains and their uses
JANSSEN BIOTECH INC0 citations41
DUMBLE MELISSA
3 patentsUS8703781B2Apr 22, 2014
Pharmaceutical combination of MEK inhibitor and B-RAF inhibitors
DUMBLE MELISSA14 citations79
US8835450B2Sep 16, 2014
Combination of inhibitor of B-Raf and an inhibitor of Akt in the treatment of cancer
DUMBLE MELISSA0 citations45
US8796298B2Aug 5, 2014
Combination of a B-Raf inhibitor: N-{3-[5-(2-Amino-4-pyrimidinyl)-2-(1,1- dimethylethyl)-1,3-thiazol-4-yl]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide and the Akt inhibitor: N-{ (1S)-2-amino-1-[(3- fluorophenyl)methyl]ethyl}-5-chIoro-4-(4-chIoro- 1 -methyl- 1 H-pyrazol-5-yl)-2-10 thiophenecarboxamide useful in the treatment of cancer
DUMBLE MELISSA1 citations45
NOVARTIS AG
2 patentsNITZ THEODORE J
2 patentsUS8575205B2Nov 5, 2013
Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
NITZ THEODORE J3 citations60
US8202896B2Jun 19, 2012
Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
NITZ THEODORE J3 citations60